Gastrointestinal side effects of intravenous erythromycin: Incidence and reduction with prolonged infusion time and glycopyrrolate pretreatment

This publication has 16 references indexed in Scilit:

• Comparison of motilin binding to crude homogenates of human and canine gastrointestinal smooth muscle tissue
  Regulatory Peptides, 1988
• Erythromycin and its derivatives with motilin-like biological activities inhibit the specific binding of 125I-motilin to duodenal muscle
  Biochemical and Biophysical Research Communications, 1988
• Comparison of the side effects and gastrointestinal motility observed after administration of erythromycin and josamycin to dogs
  Journal of Antimicrobial Chemotherapy, 1986
• Gastrointestinal side effects after intravenous erythromycin lactobionate.
  British Journal of Clinical Pharmacology, 1986
• The Assessment of Nausea and Vomiting
  Cancer, 1984
• Study of Serum Levels, Venous Irritation and Gastrointestinal Side-effects with Intravenous Erythromycin Lactobionate in Patients with Bronchopulmonary Infection
  Human Toxicology, 1983
• Cholinergic role on release and action of motilin
  Peptides, 1983
• Erythromycin (2×1 g) as a regimen for community-acquired pneumonia
  Infection, 1982
• Intersubject and dose‐related variability after intravenous administration of erythromycin.
  British Journal of Clinical Pharmacology, 1980
• Motilin
  Clinics in Gastroenterology, 1980